Report for: Opioids for neuropathic pain

Title	Opioids for neuropathic pain
Published in	Cochrane database of systematic reviews, August 2013
DOI	10.1002/14651858.cd006146.pub2
Pubmed ID	23986501
Authors	Ewan D McNicol, Ayelet Midbari, Elon Eisenberg
Abstract	This is an updated version of the original Cochrane review published in Issue 3, 2006, which included 23 trials. The use of opioids for neuropathic pain remains controversial. Studies have been small, have yielded equivocal results, and have not established the long-term profile of benefits and risks for people with neuropathic pain.

View on publisher site Alert me about new mentions

Twitter Demographics

The data shown below were collected from the profiles of 50 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Geographical breakdown

Country	Count	As %
Canada	7	14%
United Kingdom	7	14%
United States	7	14%
Spain	6	12%
Colombia	1	2%
Indonesia	1	2%
Virgin Islands, U.S.	1	2%
Chile	1	2%
Malta	1	2%
Other	3	6%
Unknown	15	30%

Demographic breakdown

Type	Count	As %
Members of the public	31	62%
Scientists	10	20%
Practitioners (doctors, other healthcare professionals)	9	18%

Mendeley readers

The data shown below were compiled from readership statistics for 390 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country	Count	As %
United States	2	<1%
Germany	1	<1%
United Kingdom	1	<1%
Australia	1	<1%
Spain	1	<1%
Iran, Islamic Republic of	1	<1%
Unknown	383	98%

Demographic breakdown

Readers by professional status	Count	As %
Student > Bachelor	55	14%
Student > Master	54	14%
Student > Ph. D. Student	41	11%
Researcher	39	10%
Other	29	7%
Other	76	19%
Unknown	96	25%

Readers by discipline	Count	As %
Medicine and Dentistry	152	39%
Nursing and Health Professions	32	8%
Pharmacology, Toxicology and Pharmaceutical Science	24	6%
Psychology	17	4%
Agricultural and Biological Sciences	12	3%
Other	44	11%
Unknown	109	28%

Attention Score in Context

This research output has an Altmetric Attention Score of 85. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 February 2023.

All research outputs

#453,190

of 23,926,844 outputs

Outputs from Cochrane database of systematic reviews

#831

of 12,770 outputs

Outputs of similar age

#3,604

of 203,523 outputs

Outputs of similar age from Cochrane database of systematic reviews

#16

of 233 outputs

Altmetric has tracked 23,926,844 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.

So far Altmetric has tracked 12,770 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 33.7. This one has done particularly well, scoring higher than 93% of its peers.

Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 203,523 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.

We're also able to compare this research output to 233 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.

Cochrane Database of Systematic Reviews

Opioids for neuropathic pain

About this Attention Score

Mentioned by

Citations

Readers on

Twitter Demographics

Geographical breakdown

Demographic breakdown

Mendeley readers

Geographical breakdown

Demographic breakdown

Attention Score in Context